Skip To Main Content
Jolien Ceusters on Muck Rack

Jolien Ceusters

As seen in: Nature, BMJ Open, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jolien

Contact Jolien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer

|
By Adriaan Vanderstichele, Jolien Ceusters, Daniela Fischerova, Antonia C. Testa
| medRxiv
TBo reports grants, personal fees, and travel support from Samsung Medison; travel support from Roche Diagnostics; and personal fees from GE Healthcare; all outside the submitted work. AC is a contracted researcher for Oncoinvent AS and Novocure and a consultant for Sotio a.s., Epics Therapeutics SA and Molecular Partners.
Open in Who Shared Issue with article?

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors

|
By An Coosemans, Jolien Ceusters, Chiara Landolfo, Thaïs Baert
| medRxiv
TBo reports grants, personal fees, and travel support from Samsung Medison; travel support from Roche Diagnostics; and personal fees from GE Healthcare; all outside the submitted work. RW is employed by Oncoinvent AS. AC is a contracted researcher for Oncoinvent AS and Novocure and a consultant for Sotio a.s., Epics Therapeutics SA and Molecular Partners.
Open in Who Shared Issue with article?

Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery | British Journal of Cancer

|
By Jolien Ceusters, Toon Van Gorp
| Nature Verified
Abstract Several diagnostic prediction models to help clinicians discriminate between benign and malignant adnexal masses are available. This study is a head-to-head comparison of the performance of the Assessment of Different NEoplasias in the adneXa (ADNEX) model with that of the Risk of Ovarian Malignancy Algorithm (ROMA).
Open in Who Shared Issue with article?
See all 4 articles